I am so excited about investing in Univec/AGRiMED/Sativeo/HCI, mainly because I strongly believe in management's ability to execute, as Doctor David L. Dalton has been in and around the pharmaceutical business his entire life and I believe the ultimate solution to the delivery of Cannabis will be through a hard pill and or transdermal patch. The problem with edibles today or infusion of any type is that they are combined with excessive sugar, and sugar is one of the killers in our society today. Consumers want something natural and the intention of this group of companies is to deliver a whole plant medicine through a hard tablet or patch that is fast acting and long lasting." Just as important, and perhaps more so, is the precise dosing promised by the combination of these companies.
Univec/AGRiMED/Sativeo/HCI is engaged in the research and development of advanced pharmaceutical grade formulations of cannabinoids. Through their partnerships, they have developed technologies to deliver standardized medical cannabis extract from selective strains in a variety of extended/sustained release pharmaceutical dosages for therapeutic use. Simply put, Univec/AGRiMED/Sativeo/HCI’s mission is to put the "Medical" into medicinal cannabis!
Kgem
(2)
(0)
Univec Conglomerate Inc (UNVC) Stock Research Links